Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study

Keywords

Humanities, Philosophy, Medicine

References

• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTIONRomain Pauwels — 1996
• A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils)Helen Petsky, Christopher J Cates, Toby J Lasserson — 2010
• Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.Eugene R. Bleecker, Eric D. Bateman, William W. Busse — 2012
• Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label studyDavid Price, Anne Robertson, Kevin Bullen — 2010
• Long-acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cells.Christos Rossios, Yasuo To, Masako To — 2011
• Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoateAnagnostis Valotis, Petra Högger — 2007
• X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain.Keith Biggadike, Randy K. Bledsoe, Anne M. Hassell — 2008
• Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.Eric D. Bateman, Eugene R. Bleecker, Jan Lötvall — 2012
• The minimally important difference of the Asthma Control Test.Michael Schätz, Mark Kosinski, Aaron Yarlas — 2009
• Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial.Jan Lötvall, Eugene R. Bleecker, William W. Busse — 2014
• Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort studyDavid Price, Amanda Lee, Erika Sims — 2013
• Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial.Eugene R. Bleecker, Jan Lötvall, Paul M. O’Byrne — 2014
• Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trialWilliam W. Busse, Eugene R. Bleecker, Eric D. Bateman — 2011
• Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled studyAnn Allen, Isabelle Schenkenberger, Roopa Trivedi — 2013
• Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthmaPaul M. O’Byrne, Eugene R. Bleecker, Eric D. Bateman — 2013
• Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthmaAshley Woodcock, Eugene R. Bleecker, William W Busse — 2011
• The Minimally Important Difference (MID) of the Asthma Control Test (ACT) Administered by TelephoneMichael Schätz, Mark Kosinski, Aaron Yarlas — 2009
• Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trialWilliam W Busse, Paul M. O’Byrne, Eugene R. Bleecker — 2013
• Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthmaM A Berry, Angela Morgan, Dominick Shaw — 2007
• Non-adherence in difficult asthma: time to take it seriouslyLiam G. Heaney, Rob Horne — 2011

Cited by

• Fluticasone furoate for the treatment of childhood asthmaHanna Phan, Mark A. Brown — 2015
• Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthmaDavid I. Bernstein, Eric D. Bateman, Ashley Woodcock — 2015
• Therapeutic Class Overview Attention Deficit/Hyperactivity Disorder (ADHD) Agents and StimulantsAdderall Xr — 2014
• Inhaled corticosteroids and incident pneumonia in patients with asthma: Systematic review and meta-analysis.Vikas Bansal, Muhammad Asif Mangi, Margaret M. Johnson — 2015
• The efficacy of fluticasone furoate administered in the morning or evening is comparable in patients with persistent asthma.Rodger Kempsford, Jo Bal, Amanda Baines — 2016
• The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experienceTimothy E. Albertson, John R. Richards, Amir A. Zeki — 2016
• Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthmaHiroshi Chantaphakul, Kiat Ruxrungtham — 2016
• Ease of use of the ELLIPTA dry powder inhaler: data from three randomised controlled trials in patients with asthmaHenrik Svedsäter, Loretta Jacques, Caroline Goldfrad — 2014
• An Integrated Analysis of Fluticasone Furoate/Vilanterol (FF/VI) Versus FF Safety Data Across Phase II and III Asthma StudiesWilliam W. Busse, Leslie Andersen, Lucy Frith — 2016
• In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)Melanie Hamilton, Richard Leggett, Cheng Pang — 2015
• The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and CaregiversA.C. Grant, Richard Walker, Melanie Hamilton — 2015
• Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthmaVicky Chang, Emma L. Gray, Paul S. Thomas — 2016
• Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trialsJohn Riley, Maggie Tabberer, Nathalie Richard — 2016
• New Inhaled Formulations for the Treatment of Asthma in Children and AdolescentsKelly Jane Lunsford — 2015
• Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthmaPaul M. O’Byrne, Loretta Jacques, Caroline Goldfrad — 2016
• Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapyTimothy E. Albertson, Samuel Bullick, Michael Schivo — 2016
• Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone FuroateRashmi Mehta, Alison Moore, Kylie Riddell — 2017
• The Frequency and Risk Factors for Oropharyngeal Candidiasis in Adult Asthma Patients Using Inhaled Corticosteroids.Tuba Erdoğan, Gül Karakaya, Alı Fuat Kalyoncu — 2019
• Fluticasone Furoate: A Once Daily Preparation in Patients with Persistent AsthmaPaul Lilburn, Henry W. Ainge‐Allen, Paul S. Thomas — 2019
• Short-term effect of once-daily fluticasone furoate on methacholine-induced bronchoconstriction in mild asthmatics.Chiamaka S. Okonkwo, Beth E. Davis, Christianne M. Blais — 2019

Related papers

No related papers recorded.